Revance Therapeutics Overview

Revance Therapeutics Gross Profit

Gross Profit analysis for RVNC.

Quarterly Gross Profit

$42.25M

↑ 13.07% YoY

As of Sep 30, 2024

Annual Gross Profit (TTM)

$174.52M

↑ 30.48% YoY

Trailing 12 months ending Sep 30, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin